We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$31B
AUM Growth
+$5.1B
Cap. Flow
+$4.42B
Cap. Flow %
14.26%
Top 10 Hldgs %
15.35%
Holding
1,525
New
241
Increased
776
Reduced
376
Closed
66

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$132M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$114M
3
AMZN icon
Amazon
AMZN
+$89.2M
4
MSFT icon
Microsoft
MSFT
+$88.1M
5
META icon
Meta Platforms (Facebook)
META
+$85M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$64.5M
3
YHOO
Yahoo Inc
YHOO
+$41.6M
4
CUK
Carnival PLC
CUK
+$36.5M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$31.3M

Sector Composition

Rank Sector Weight
1 Financials 17.48%
2 Technology 15.7%
3 Healthcare 13.87%
4 Industrials 10.19%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
1401
Corbus Pharmaceuticals
CRBP
$189M
$202K ﹤0.01%
+1,067
New +$209K
ADXS
1402
DELISTED
Advaxis Inc
ADXS
$201K ﹤0.01%
+2,067
New +$242K
TTPH
1403
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$200K ﹤0.01%
+1,400
New +$216K
SCMP
1404
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$199K ﹤0.01%
+19,000
New +$194K
VIVS
1405
VivoSim Labs
VIVS
$1.16M
$196K ﹤0.01%
+313
New +$210K
CMRX
1406
DELISTED
Chimerix, Inc.
CMRX
$185K ﹤0.01%
+34,000
New +$179K
CNCE
1407
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$181K ﹤0.01%
+13,000
New +$192K
LCTX icon
1408
Lineage Cell Therapeutics
LCTX
$281M
$180K ﹤0.01%
+65,151
New +$182K
CCXI
1409
DELISTED
ChemoCentryx, Inc.
CCXI
$178K ﹤0.01%
+19,000
New +$139K
MCRB icon
1410
Seres Therapeutics
MCRB
$47.6M
$169K ﹤0.01%
+750
New +$154K
OCUL icon
1411
Ocular Therapeutix
OCUL
$2.23B
$167K ﹤0.01%
+18,000
New +$174K
CEMP
1412
DELISTED
Cempra, Inc.
CEMP
$166K ﹤0.01%
+36,000
New +$142K
CRIS icon
1413
Curis
CRIS
$3.74M
$163K ﹤0.01%
+43
New +$180K
TFSL icon
1414
TFS Financial
TFSL
$4.89B
$162K ﹤0.01%
10,467
-850
-8% -$13.7K
NTLA icon
1415
Intellia Therapeutics
NTLA
$1.69B
$160K ﹤0.01%
+10,000
New +$140K
NERV icon
1416
Minerva Neurosciences
NERV
$194M
$159K ﹤0.01%
+2,250
New +$146K
MYOK
1417
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$157K ﹤0.01%
+12,000
New +$158K
PDSB icon
1418
PDS Biotechnology
PDSB
$13.5M
$154K ﹤0.01%
+750
New +$148K
AVXL icon
1419
Anavex Life Sciences
AVXL
$323M
$151K ﹤0.01%
+29,000
New +$168K
DRRX
1420
DELISTED
DURECT Corp
DRRX
$151K ﹤0.01%
+9,700
New +$111K
CPRX
1421
DELISTED
Catalyst Pharmaceutical
CPRX
$149K ﹤0.01%
+54,000
New +$113K
STML
1422
DELISTED
Stemline Therapeutics, Inc.
STML
$147K ﹤0.01%
+16,000
New +$133K
VCYT icon
1423
Veracyte
VCYT
$3.58B
$142K ﹤0.01%
+17,000
New +$139K
CLSD
1424
DELISTED
Clearside Biomedical
CLSD
$137K ﹤0.01%
+1,000
New +$120K
MNOV icon
1425
MediciNova
MNOV
$65M
$137K ﹤0.01%
+26,000
New +$146K
55 56
57
58 59

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q2 2017 Portfolio in Review

As of Q2 2017, State of Wisconsin Investment Board held 1,525 positions worth $31B, up 20% from $25.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

State of Wisconsin Investment Board deployed $4.42B of net new capital in Q2 2017, opening 241 new positions and adding to 776 existing holdings. Its largest new stake was Altaba Inc: 1,221,540 shares worth $66.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $64.5M trimmed.

  • State of Wisconsin Investment Board's largest Q2 2017 buy was Altaba Inc: 1,221,540 shares worth $66.5M.
  • State of Wisconsin Investment Board added most to Apple in Q2 2017, an estimated $132M increase.
  • State of Wisconsin Investment Board's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $64.5M.
  • State of Wisconsin Investment Board fully exited State Street SPDR S&P Biotech ETF in Q2 2017, selling an estimated $105M.
  • State of Wisconsin Investment Board's ten largest holdings make up 15% of its $31B portfolio in Q2 2017.
  • State of Wisconsin Investment Board opened 241 new positions and closed 66 in Q2 2017.
  • State of Wisconsin Investment Board's portfolio value rose 20% quarter-over-quarter to $31B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2017, filed 3 Aug 2017.